Wildflower Brands Teams with Highmark Interactive to Sponsor Clinical Research in CBD
VANCOUVER, British Columbia, May 2, 2019: Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “Company”) is excited to announce the signing of an agreement with Highmark Interactive to study the cognitive and functional neurological effects of cannabinoids through clinical research leveraging Highmark’s industry-leading mobile software, EQ – Active Brain Tracking.
Wildflower Brands has a product lineup of effective plant-based remedies that has amassed a loyal following throughout the US. With the explosive growth of interest in cannabinoids coming into the mainstream, research and data is important for both consumers and the industry. Highmark Interactive’s innovative, leading-edge software and dedication to brain health and wellness aligns closely to the values and vision of Wildflower Brands. The goal of the research sponsorship is to create meaningful data and results that could unlock new avenues of understanding about the cognitive and functional neurological effects of cannabinoids.
William MacLean, CEO of Wildflower Brands, says, “Wildflower continues to receive a flood of testimonials from consumers on our products that support wellness and health needs through plant based solutions. We always strive for improvements in our products and our understanding of those products, and this research commits us to that goal as an investment in the growth of our industry. Highmark Interactive brings the right skills and relationships to the table and we are excited to see the results of our work together.”
Dr. Sanjeev Sharma, Co-Founder and CEO of Highmark Interactive, says, “Highmark Interactive’s EQ – Active Brain Tracking represents evolution in neurological testing and analysis. Being used in countries around the world, the proprietary algorithms within the software enable neurological testing within a variety of sectors in a mobile, accessible, and holistic manner. In partnering on this research with a prominent industry leader like Wildflower, we are excited to pursue a deeper understanding of the relationship between cannabinoids and our brain’s functioning, which could have meaningful applications in the future”.
ABOUT HIGHMARK INTERACTIVE
Highmark Interactive is a Canadian-based medical technology company with a focus on assessing neurological functional performance and how it is affected after mild traumatic brain injuries and other neurological diseases. Founded in 2017, Highmark’s mission is to use engaging, mobile-focused games that test a variety of neurologic functions to facilitate a more accurate clinician assessment.
You can download “EQ Active Brain Tracking” for iOS and Android on the App Store and Google Play store.
Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of our brands work in synergy, toward becoming a global wellness leader.
Investor Relations Contact:
Will Elston, Investor Relations
1-604-559-0420 ext. 111
Cautionary and Forward-Looking Statements
This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Forward‐looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.